NCT06258577Not yet recruiting
Screening for Gaucher Disease and Acid Sphingomyelinase Deficiency
Screening for Gaucher Disease and Acid Sphingomyelinase Deficiency From Taiwanese Candidates With Splenomegaly and/or Thrombocytopenia
Source: ClinicalTrials.gov · Last updated 15 Apr 2024 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
High-risk screening for Gaucher disease and Acid Sphingomyelinase Deficiency in patients with splenomegaly and/or thrombocytopenia in Taiwan
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 50 (estimated)
- First submitted
- 6 Feb 2024
- Start date
- 1 May 2024
- Primary completion date
- 31 Dec 2028
- Lead sponsor
- Chung-Hsing Wang
- Diseases
- Gaucher disease
- NCT number
- NCT06258577
What you commit to
- Study type: Observational
- Planned participants: 50
- From 1 May 2024 to the primary completion date, 31 Dec 2028
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Clinical diagnosis of gaucher disease
- Clinical diagnosis of malignant tumors
Other
- Clinical diagnosis of acid sphingomyelinase
Who the study is looking for
- Clinical diagnosis of splenomegaly
- Clinical diagnosis of thrombocytopenia
Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| China Medical University Hospita Coordinator of this site? Confirm its status | Taichung | Taiwan | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.